Kush Parmar
10% Owner; Director; Director, 10% Owner · 5 filings · Latest: Aug 10, 2026
Camp4 Therapeutics Corp
Entrada Therapeutics, Inc.
Latigo Biotherapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TRDA | Kush Parmar | Director | Aug 10, 2026 | Sale | $7.00 | 92,444 | $647.1K | 2,691,337 | |
TRDA | Kush Parmar | Director | Aug 7, 2026 | Sale | $6.85 | 52,317 | $358.4K | 2,783,781 | |
TRDA | Kush Parmar | Director | Aug 6, 2026 | Sale | $7.00 | 10,494 | $73.5K | 2,836,098 | |
TRDA | Kush Parmar | Director, 10% Owner | Jul 31, 2026 | Sale | $6.85 | 1,718 | $11.8K | 2,846,592 | |
TRDA | Kush Parmar | Director, 10% Owner | Jul 30, 2026 | Sale | $6.93 | 114,756 | $795.3K | 2,848,310 |